Paladin - Corporate Info CORPORATE INFO FOR INVESTORS OUR PRODUCTS BUSINESS DEVELOPMENT CONTACT US HOME Menu Overview Mission Statement Strategy History Management Team Board of Directors News Press Releases Corporate News Awards - A BRIEF HISTORY OF PALADIN LABS INC.- 1996 --- 1997 --- 1998 --- 1999 --- 2000 --- 2001 --- 2002 --- 2003 --- 2004 --- 2005 1995 & Before – Summary In 1995, Mr.
Microsoft Word - PLB News 10- Vantas NON.doc NEWS RELEASE HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON VANTAS ® NEW DRUG SUBMISSION Montreal, Canada, June 16, 2005 Paladin Labs Inc.
author: Manon Bouffard
Montreal, Canada, June 16, 2005 - HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON VANTAS® NEW DRUG SUBMISSION FOR IMMEDIATE RELEASE HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON VANTAS® NEW DRUG SUBMISSION Montreal, Canada, June 16, 2005 - Paladin Labs Inc.
BioPortfolio Limited Cancer Overview - Numerous Diverse Drugs Approaching Fruition TABLE OF CONTENTS About the Oncology pharmaceutical analysis team 2 Richard Faint – Director of Oncology 2 CHAPTER 1 KEY FINDINGS 3 Datamonitor insight into the oncology market 3 Key metrics 9 Datamonitor pipeline assessment summary 17 CHAPTER 2 CANCER PATIENT POTENTIAL 38 Introduction 38 Definition of cancer 38...
http://www.paladin-labs.com/pdf_files/Trelstar_Primer.pdf 1 Trelstar ® 2 Trelstar ° Triptorelin pamoate – LHRH agonist ° Approved in Canada for the treatment of endometriosis and prostate cancer but never launched ° Available in two formats: 1 and 3 month IM injection ° Marketed in Europe as Decapeptyl ° Approved in US and just launched by Watson ° Competes in a growing market of $125MM – TRx 5-...
Database L L - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt IN NOBEOKA CITY, JAPAN." 9913 29-Sep-92 HYDRO MED SCIENCES "HISTRELIN (LHRH AGONIST) IMPLANTS AS MFG
http://www.fda.gov/cder/dmf/text/4Q2003NEWTEXT.txt "INJECTION BLOW MOLDED PLASTIC BOTTLES AS MANUFACTURED IN LJUBLJANA, SLOVENIA." 16995 II 3-Dec-2003 TEVA GROUP "TOLTERODINE TARTRATE AS MANUFACTURED IN BE'ER SHEVA, ISRAEL." 16996 II 3-Dec-2003 TEVA GROUP "LOSARTAN POTASSIUM AS MANUFACTURED IN BEER SHEVA, ISRAEL." 16997 II 30-Oct-2003 BACHEM AG "HISTRELIN ACETATE AS MANUFACTURED IN BUBENDORF, SWITZERLAND." 16998 II 1-Dec...
http://www.fda.gov/cder/dmf/xls/4Q2003NEWEXCEL.xls Arthur Shaw CDER User $ ($) $ ($) $ ($) $ ($) $ $ () $ - () - $ $ () $ - () - -- -- $ ($) $ ($) $ ($) $ ($) / / // -- - - : : :: : () () () () () - $ $ () $ - () - $ $ () $ - : :: : 4Q2003NEWEXCEL DMF # Type SUBMIT DATE HOLDER SUBJECT IV COGNIS DEUTSCHLAND GMBH CO KG MYRITOL(R) 318 PH AS MANUFACTURED IN DUESSELDORF, GERMANYACETATE) ...
Prescription and OTC Drug Product List 6/2002 ACTHAR GEL -D- BC + QUESTCOR PHARMS 40 UNITS/ML N08372 006 JUL DISC -A- @ 40 UNITS/ML N08372 006 JUL DISC DIATRIZOATE SODIUM SOLUTION; ORAL, RECTAL HYPAQUE -D- AMERSHAM HLTH 40% N11386 003 JUL DISC -A- @ 40% N11386 003 JUL DISC DICLOFENAC SODIUM GEL; TOPICAL SOLARAZE -A- + BIOGLAN PHARMA 3% N21005 001 OCT 16, 2000 JUL CAHN -D- + BIOGLAN PHARMA PLC 3% N21005 001 OCT 16, 2000 JUL CAHN...
http://www.freseniushc.com/product/April_1_2001_Update.pdf April 1 2001 Update Addendum A. Update of Calendar Year 2001 Hospital Outpatient Payment Rates and Coinsurance Amounts Effective April 1, 2001 National Minimum Status Relative Payment Unadjusted Unadjusted APC Group Title Indicator Weight Rate Coinsurance Coinsurance 0001 Photochemotherapy ...
http://www.freseniushc.com/product/April_1_2001_Update.pdf page 8 April 1 2001 Update 1024 Quinupristin 150 mg/ dalfopriston 350 J $102.05 $13.67 $13.67 1045 I- 131 MIBG (ioben- sulfate) O. 5mCi G $1,140.00 $139.08 $139.08 1059 Carticel, auto cult- chndr cyte G $14,250.00 $2,010.00 $2,010.00 1079 CO 57/ 58 0.5 mCi G $264.10 $32.22 $32.22 1084 Denileukin diftitox, ...
